The company is exposed to risks from volatility in global credit and financial markets, which may affect the availability and cost of financing. It has initiated a transformation plan that includes consolidating manufacturing operations and relocating some manufacturing offshore to improve margins. As of December 31, 2025, the company reported total indebtedness of approximately US$141.3 million. This includes a senior secured term loan from Perceptive Credit Holdings III, LP, a convertible note issued to MiCo IVD Holdings, LLC, and deferred consideration related to the acquisition of biosensor assets from Waveform. The term loan balance was US$108.0 million, and on December 22, 2025, the term loan obligations to Perceptive Credit Holdings III, LP were restructured into a new senior convertible note with a principal balance of approximately US$95.8 million.
Trinity Biotech Plc's Comment on Supply Chain
The company is exposed to risks from volatility in global credit and financial markets, which may affect the availability and cost of financing. It has initiated a transformation plan that includes consolidating manufacturing operations and relocating some manufacturing offshore to improve margins. As of December 31, 2025, the company reported total indebtedness of approximately US$141.3 million. This includes a senior secured term loan from Perceptive Credit Holdings III, LP, a convertible note issued to MiCo IVD Holdings, LLC, and deferred consideration related to the acquisition of biosensor assets from Waveform. The term loan balance was US$108.0 million, and on December 22, 2025, the term loan obligations to Perceptive Credit Holdings III, LP were restructured into a new senior convertible note with a principal balance of approximately US$95.8 million.
Sources:
Trinity Biotech Plc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Trinity Biotech Plc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
